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Raman spectroscopy: an evolving technique for
live cell studies
Rachael Smith,a,b Karen L. Wrightb and Lorna Ashton*a
One of the most exciting developments in Raman spectroscopy in the last decade has been its application
to cells and tissues for diagnostic and pharmaceutical applications, and in particular its use in the analysis
of cellular dynamics. Raman spectroscopy is rapidly advancing as a cell imaging method that overcomes
many of the limitations of current techniques and is earning its place as a routine tool in cell biology. In
this review we focus on important developments in Raman spectroscopy that have evolved into the excit-
ing technique of live-cell Raman microscopy and highlight some of the most recent and significant appli-
cations to cell biology.
Introduction
The cell is the basic biological unit of all living organisms, and
the understanding of cellular dynamics and processes is vital
for biological research as most diseases occur as a result of cel-
lular abnormalities due to intracellular biochemical changes.1
Cell imaging allows these intracellular biochemical changes,
along with normal behaviour, to be observed. Raman spec-
troscopy is an advancing cell imaging method that overcomes
some of the limitations of current techniques.
Raman spectroscopy is a measure of the Raman effect, or
inelastic scattering, first discovered by C. V. Raman in 1928.2
He and K. S. Krishnan described the observation of a ‘new
type of secondary radiation’ after experiments that involved
illuminating samples with sunlight focused through a lens.
They observed scattered light with a different wavelength to
the original, incident wavelength; this scattering is now known
as Raman scattering. This is induced by monochromatic light,
usually from a laser, directed onto the cell; photons interact
with this sample and energy can either be lost (Stokes) or
gained (anti-Stokes). This difference in energy between the
incident and scattered photon corresponds to the energy
required to excite a particular molecular vibration; detection of
these scattered photons produces a Raman spectrum, with
different bands corresponding to the vibrational frequencies
of different functional groups. Each molecule therefore has a
unique fingerprint, or spectrum, according to the chemical
bonds within it.3
While for cells these spectra can be complex, containing
information about many different molecules and often requir-
ing complex data interpretation, the potential of Raman spec-
troscopy in live cell imaging cannot be ignored. One of the key
advantages of Raman spectroscopy is the ability to determine
the underlying chemical structure of a cell: proteins, lipids
and DNA can be visualised according to their vibrational
spectra and as a result cells do not need to be labelled or
stained prior to imaging.4 Furthermore, as water has a weak
Raman signal, cells can be imaged within aqueous environ-
ments, meaning that live cell imaging is possible and making
Raman spectroscopy an exciting alternative to existing imaging
methods, allowing for the observation of living cells under
normal physiological conditions.
Numerous other imaging techniques are currently used
today in order to visualise cells. Historically, cell imaging was
carried out only on fixed cells, primarily by electron microscopy.
While providing valuable structural and biochemical infor-
mation, these techniques only provide a ‘snapshot’ of the cells
current state.5 In addition, cells often have to be stained prior
to imaging, which has the potential to introduce artefacts and
give an inaccurate representation of the natural intracellular
state. The development of brightfield microscopy based tech-
niques such as phase contrast and differential interference con-
trast microscopy meant that cells could be observed without
staining, and live cell imaging became a possibility.6 Images
obtained via these techniques can typically be collected more
quickly than those acquired via Raman spectroscopy, but there
is a lack of chemical specificity and there is the potential for
artefacts to be introduced due to the halo affect.7
More recently, live cell imaging has been carried out using
fluorescence microscopy, which allows for the detection of
single molecules within a cell. Fluorescence microscopy is
used to visualise the pattern of fluorescence within cells that
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have been stained with fluorescent molecules. The resolution
of images achieved via fluorescence microscopy can be
improved by techniques like STORM (stochastic optical recon-
struction microscopy) or PALM (photo-activated localization
microscopy) which sequentially selectively activate fluoro-
phores throughout a single cell (for more detail on these tech-
niques see ref. 8). Both of these techniques have been used in
a number of live cell studies.9–11 FRET (fluorescence resonance
energy transfer) is another fluorescence-related technique that
can be used to detect and image protein–protein interactions
within cells to give insight into cellular events like signal trans-
duction and gene transcription.12 Whilst generally, these tech-
niques have the advantage of giving a better resolution than
can typically be achieved with Raman spectroscopy (down to
∼10 nm (ref. 13)), Raman spectroscopy has the advantage of
increased chemical specificity and a lack of labels. Fluorescent
microscopy relies on the expression of fluorescent molecules
within cells, often by introducing external genes,6 which can
directly affect cell physiology14,15 and as such, fluorescence
imaging may not reflect the normal cellular environment in
comparison to Raman-related techniques.
Infrared spectroscopy (IR) is another vibrational spec-
troscopy technique that can be utilised for live cell imaging. IR
spectroscopy shares many of the advantages of Raman spec-
troscopy, in that it is non-invasive, non-destructive, and identi-
fies the underlying chemical structure and as a result does not
require labels. However, as water is a strong absorber of infrared
radiation3 this can make the analysis of substances in an
aqueous environment difficult; Raman spectroscopy is therefore
usually preferred over IR spectroscopy as cells can be maintained
under physiological conditions. Additionally, Raman spec-
troscopy is typically able to achieve a better resolution.16
Due to its advantages over current techniques, there is a
huge interest in developing Raman spectroscopy and imaging
in biomedicine, with a particular emphasis on its potential for
non-invasive in vivo disease diagnosis.
Single cell Raman spectroscopy
Currently, despite its advantages and potential, Raman spec-
troscopy is not widely used in clinical practice. This is primar-
ily due to the fact that spontaneous Raman scattering is an
inherently weak process, with only approximately 1 × 108 of
photons inelastically scattered.3 Traditionally, this has resulted
in long acquisition times and high laser intensity which is det-
rimental in examining biological samples and results in degra-
dation.31 However, a number of new developments, techniques
and instrumentation are starting to overcome these limitations
(summarised in Fig. 1), leading to vast improvements and
allowing for cell imaging via Raman spectroscopy to become a
viable alternative to traditional methods. One of the most
important step-changes in single cell Raman spectroscopy was
the combining of a Raman spectrometer with a standard con-
focal microscope, the typical set-up of which can be seen in
Fig. 2 below. In this technique, the laser beam is focused onto
the cell by a microscope lens in order to give a much better
resolution than can be achieved with traditional Raman spec-
troscopy.26 By coupling the Raman spectrometer to a camera,
usually a charged-coupled device (CCD), confocal Raman spec-
troscopy is able to image or map samples in addition to col-
lecting their Raman spectra, allowing for the visualisation of
intracellular components.32 Wide-field Raman imaging is a
direct approach that illuminates the entire sample with a laser,
and a narrowband filter is used to measure a specific wavenum-
ber range. Raman mapping is more commonly used in cell
studies, and traditionally involves raster-scanning a confocal
laser spot and collecting the full Raman spectra sequentially at
each location across the sample after dispersion onto the
spectrometer CCD.23,33 A Raman map can them be computa-
tionally constructed to produce a pseudo-coloured image
shaded according to the relative intensity of the Raman spectra
at a given wavelength at each pixel.34 The first confocal Raman
microscope was described in 1990, and was used to visualise
and study single cells and chromosomes with a high spatial
resolution.26 Since 1990, many different studies have been
carried out using confocal Raman spectroscopy to map cells.
As with many traditional cell imaging techniques, cells
were initially fixed for these Raman spectroscopy experiments.
Fixatives are used to preserve and to prevent the degradation
of biological samples before they can be observed microscopi-
cally. The main fixatives used in Raman microscopy are alco-
hols (which fix samples by disrupting the hydrophobic bonds
within proteins to denature them) and aldehydes (crosslinking
fixatives that work by inducing covalent bonds between pro-
teins).35 In fixed cells, Raman microspectroscopy has been
used to map and visualise cell organelles, including: DNA by
detecting the intensity of the 788 cm−1 band, associated with
nucleic acids;36 proteins by measuring the bands for alkane
groups at 2850 cm−1, 2885 cm−1 and 2935 cm−1;37 lipid bodies
by measuring the intensity of bands at 1658 cm−1, 1267 cm−1
and 1411 cm−1;38 and mitochondria by using bands at
750 cm−1, indicative of cytochrome c distribution.39 In
addition to this, studies on fixed cells have also been used to
image cells at different stages of the cell cycle,40 to show sub-
cellular changes that occur as a result of the stress-induced
response,41 and to identify differences between benign and
malignant breast tissue.42
However, whilst all of these above studies have provided
valuable biochemical information, there is evidence that fixing
procedures may alter the Raman spectra of cells in comparison
to unfixed cells treated in the same way. Chan et al. reported
changes in the intensity of bands associated with DNA, RNA,
protein and lipid vibrations between fixed and unfixed cells,
with methanol fixation showing greater changes than parafor-
maldehyde.43 A more recent study supported this, with ethanol
inducing a greater change in the Raman spectra of nucleolar
components than formaldehyde,44 and it has also been shown
that formalin fixation induces changes in the Raman spectra
of nucleic acids and proteins.45,46 Together, this data suggests
that studies on fixed cells may not give accurate Raman
spectra and has the potential to lead to data being misinter-
preted, and studies on live cells are necessary to overcome this
and to give more accurate results.
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Raman microscopy is ideal for live cell studies, because it does
not require the use of labels that may harm cells, and because
it can be carried out in aqueous conditions due to the weak
Raman intensity of water, cells can be imaged in either phos-
phate buffer solution (PBS) or medium, so do not need to be
fixed prior to imaging. Many live cell studies use a laser with a
wavelength of 785 nm, just outside of the visible range. This is
because there is evidence that visible wavelengths can cause
degradation and photodamage to biological samples even at a
low power and with short acquisition times.31,47 In contrast, it
has been shown in several studies that a 785 nm laser does not
cause this degradation, even with a high power and longer
acquisition times,3,48 making it the preferred wavelength for
the study of living cells.
Since the development of live-cell Raman imaging, many
studies using living cells have been carried out and Raman
microscopy has proved to be an important imaging technique
in a number of different research areas. Initial Raman spec-
troscopy studies on live cells acquired spectra of cells
immersed in PBS. One of the earliest studies occurred in 2005,
when Wood et al. used Raman spectroscopy in order to image
the oxygenation process of haemoglobin in human erythro-
cytes. Red blood cells were isolated from healthy volunteers
and suspended in PBS before being transferred to a Petri dish
for Raman measurements. Cells were imaged in the
1210–1250 cm−1 region over a period of 90 minutes; during
Fig. 1 A timeline of the key events in the history of Raman spectroscopy that have led to significant advancements in the field.2,17–30
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the first 50 minutes, cells were deoxygenated (by the addition
of nitrogen), before being reoxygenated by atmospheric
oxygen. Changes in the intensity of the measured band meant
that the process could be followed and demonstrated the
potential of Raman spectroscopy for single cell analysis of
erythrocytes.47 Confocal Raman spectroscopy has also been
applied to other cell types, and has been used to construct
maps of lung carcinoma cells,49 and glioma cells,50 showing
the distribution of nucleic acids, cell membrane lipids and
proteins in both of these cell types. Both of these studies had
an acquisition time of between 45–60 minutes, and while
there was little loss of cell viability,49 this acquisition time is
still long for biological samples and could be improved. More
recent studies, including the investigation of hemozoin uptake
in macrophages51 demonstrate that collection times can be
reduced to 5–12 minutes depending on the cell size. The reso-
nance effect can also be exploited in order to reduce acqui-
sition times. In this technique, the frequency of the laser is
adjusted so that it coincides with an electronic transition of
the molecule of interest in order to enhance the Raman scatter
and allow for high contrast spatial distribution imaging.3 This
has been used in a number of Raman experiments to map the
intracellular distribution of a number of different molecules in
fixed cells,52,53 and more recently in living cells to visualise
changes in cytochrome c distribution during apoptosis.39
Studies such as these highlight the potential of Raman spec-
troscopy for not only determining different cell types, but also
as an analytical tool to monitor biochemical changes in single
cells in response to changes in the medium and cell culture
conditions.
While studies in PBS have proved useful for studying bio-
chemical processes, they do not give an accurate representa-
tion of normal physiological conditions, or as close as is
possible in vitro. The need for in vitro models is great,
especially in the field of drug development and cellular
response to specific compounds, but also in terms of studying
differences between normal and diseased or malignant cells
and tissues in order to potentially develop Raman spec-
troscopy as a diagnostic tool. This has led to the development
of Raman spectrometers that can be coupled to a cell incuba-
tor, allowing cells to be maintained under normal physiologi-
cal conditions (37 °C and 5% carbon dioxide).32 In ‘true’ live
cell studies, cells are usually seeded directly onto the Raman
substrate, held within sample holders or chambers – these are
then immersed in medium and placed inside the incubator
within the Raman microscope (Fig. 3). Several commercial
microscope incubators are now available that include the incu-
bator and the facilities to control the humidity, temperature
and carbon dioxide and oxygen levels enabling cells to be kept
alive for days at a time. Single cells have been mapped in this
way by confocal microscopy to visualise the nucleus and cyto-
plasm of human breast cancer cells over a period of several
hours, showing the potential of Raman spectroscopy in time-
course studies.32
Fig. 2 Standard configuration of a confocal Raman microscope.
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At present there are two major limitations in the translation
of live cell Raman spectroscopy from the laboratory into the
clinic: difficulties in analysing the data and as previously men-
tioned slow acquisition times. There is often a misconception
outside of the field of Raman spectroscopy that data analysis
is difficult and time consuming for non-specialists. Although
there is no standardized approach for how to do this, with
different groups using different methods,34 rapid improve-
ments in data analysis software supplied with Raman spec-
trometers is making it easier and quicker to convert the
Raman maps into meaningful pictures. However, there is still
a need for those carrying out single cell Raman spectroscopy
to work together to establish robust and reliable protocols that
are user-friendly and applicable to cell biology. As previously
discussed, progress is being made with the second limitation
of slow acquisition times.
One method to increase imaging speed as well as gaining
increased chemical specificity is stable-isotope labelling
(SILAC), primarily using amino acid isotopes. These can be
easily incorporated into all newly synthesised proteins within
cells by being added to the culture medium, and are an excit-
ing labelling method as, unlike the fluorophores mentioned
earlier in this review, there is little chemical difference
between these isotopes and the natural amino acid, meaning
that cellular behaviour will not be altered.54 The incorporation
of stable isotopes within cells will shift the Raman band at a
particular frequency which can be observed and used for label-
ling purposes. This technique has been used in a number of
Raman-based studies to further investigate cell physiology and
behaviour beyond the limitations of traditional Raman micro-
scopic techniques. SILAC has been combined with Raman
spectroscopy to show the previously unobserved localisation of
newly synthesised proteins to lipid droplets in live yeast cells,55
to visualise the uptake and distribution of labelled lipids and
the subsequent formation of cytosolic lipid droplets during
the process of macrophage foam cell formation,56 to study
carbon flow from an amino acid source to predatory nema-
todes via E. coli,57 and to, for the first time, observe the
exchange of amino acids between a host cell and an infecting
parasite, T. gondii, in real time.58
As well as improvements in collection times for convention-
al Raman spectroscopy two further Raman approaches have
been shown to significantly reduce acquisition times: coherent
anti-Stokes Raman spectroscopy (CARS) and surface enhanced
Raman spectroscopy (SERS).
CARS is a nonlinear technique that measures the anti-
Stokes shift rather than the Stokes shift. CARS achieves this by
using a pump beam at frequency ωp and a Stokes beam at fre-
quency ωs to tightly focus onto a cell, generating an anti-
Stokes signal at a frequency of 2ωp − ωs. If this frequency is
equal to the frequency of the molecular vibration of a particu-
lar chemical bond, then a strong signal is generated as all
these molecules are converted into a vibrational state at the
same time.59 As only a single vibrational frequency is exam-
ined at any one time, CARS is a highly selective imaging tech-
nique with a signal that is 5–6 orders of magnitude greater
than that observed in the spontaneous Raman scattering
process, meaning that CARS is particularly useful for the study
of specific molecules within a cell. As traditional CARS is
limited to study only a single Raman peak, it has most com-
monly been used to examine lipid distribution in cells, due to
the abundance of C–H bonds within lipids. It has been used to
map lipid droplet distribution by measuring the vibrational
frequency at 2845 cm−1, and to follow cellular differentiation
of live fibroblast cells into fat cells over a period of several
days.60 It has also been used to visualise the nuclear mem-
brane during interphase and chromosomes during metaphase
in living cells, as well as to observe the process of apoptosis,
again in fibroblast cells.61
SERS is a technique that aims to increase the weak Raman
intensity associated with spontaneous scattering, and in some
cases has increased the intensity to such an extent that single
molecule detection has been achievable.27 In SERS, a metallic
nanostructure is used as a substrate (typically silver or gold);
when this surface interacts with incident photons, an
enhanced electric field is generated, increasing Raman scatter-
ing from molecules near to or adsorbed onto the substrate
(reviewed in detail in ref. 62). For cell-based studies, cells can
be incubated with a metal colloid suspension in order to give
high resolution intracellular images with a short acquisition
Fig. 3 Schematic of a typical live cell incubator set-up for combining with Raman spectroscopy. While this is the typical set up by commercial
manufacturers, some live cell experiments for long-term studies use an inverted microscope as unlike this set-up, the microscope objective does
not need to be immersed in media.32
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time.63 These nanoparticles can be targeted towards organelles
of interest in order to map organelles within living cells, and
this technique has been used in a number of different studies.
Gold nanoparticles have been used in order to visualise the
nucleus of human oral squamous carcinoma cells as they
passed through the cell cycle over a period of 24 hours,
showing clearly the changes in nuclear structure as cells pro-
gressed from G1 through to M phase.64 Another recent study
used dye-coded gold nanoparticles modified with peptides to
target the cytoplasm, mitochondria and nucleus of human
oral cancer cells. Cells were incubated with these particles for
either three, six or twelve hours prior to Raman spectral acqui-
sition. The use of gold nanoparticles increased the Raman
intensity by such a factor that acquisition times of 10 ms per
pixel could be used to map mitochondria and the nucleus,
resulting in a total spectral acquisition time of just 27.5
seconds.65
It is worth noting that a number of other instrumental or
sampling approaches can be used in order to increase imaging
speed without resorting to CARS and SERS in order to obtain a
full spectrum across the whole cell without the introduction of
nanoparticles. Selective sampling can be used in order to
reduce acquisition times, and involves taking the Raman
spectra at selected points rather than raster scanning the
whole sample, and is particularly useful in studies were only a
particular part or structure of the cell is of interest. This
methodology has been used in order to measure Raman
spectra of a parasite, Neospora caninum, invading host cells,
reducing acquisition times by up to ten times in comparison
to raster scanning.66 Multi-focal scanning is another technique
that can increase the speed of spectral acquisition, and has
been able to acquire Raman maps of bacterial spores in
∼1 minute.67
Together, these studies demonstrate the ability of Raman
spectroscopy to provide valuable biochemical information
from living cells in a relatively short space of time, allowing for
the real-time observation and monitoring of cellular processes
in vitro in a way that other current imaging techniques cannot.
Current and potential applications of live-cell imaging
Stem cell identification and characterisation. Stem cells are
undifferentiated cells able to differentiate into a number of
different cell lineages, and are important in a number of
different research areas. With development, stem cell based
therapies have the potential to be used to treat a number of
different diseases, including (but not limited to): diabetes,
liver disease, degenerative neural disease and muscular dystro-
phies.68 A major limitation within this field is the hetero-
geneous nature of stem cell cultures, as specific cell
phenotypes are required for the treatment of different dis-
eases, and the proliferation of undesirable phenotypes can be
detrimental.69 Current techniques to identify and characterise
stem cell phenotype are limited and need to be improved
before stem cell isolation can be translated into the clinic. As
Raman spectroscopy is a non-invasive and label-free technique
it is already advantageous over current methods and allows for
the characterisation of living cells in vitro.
Different cell types express different molecular markers,
and these can be exploited in order to characterise and sort
specific cell types from a heterogeneous population of cells.
Pascut et al. utilised molecular markers specific for hESC-
derived cardiomyocytes, glycogen (band at 860 cm−1) and myo-
fibril proteins (band at 938 cm−1), in order to specifically
image cardiomyocytes in a population of other hESC-derived
cells with a high level of accuracy for phenotypic identifi-
cation.70 This study demonstrated the potential of Raman
spectroscopy in characterising hESC phenotype in a non-inva-
sive manner, which is vital for the cell sorting and purification
required for the clinical application of stem cell based thera-
pies, but acquisition times were long and therefore inappropri-
ate for translation into the clinic. However, the same group
managed to decrease acquisition times to just 5 seconds per
cell in a more recent study,71 making strides towards Raman
spectroscopy mediated cell identification and sorting to be
used in the clinic. The same technique has been applied to
neural stem cells, using RNA content as a molecular marker
(peak at 813 cm−1) in order to map them and to distinguish
these cells from glial cells72 (see Fig. 4), demonstrating the ver-
satility of this technique to detect different stem cell
phenotypes.
More recently, Raman spectroscopy has been used to
characterise the differentiation of adipose derived stem cells
(ADSCs) over a period of 14 days73 and dental pulp stromal
cells (DPSCs) over a period of 28 days74 under aseptic con-
ditions. The authors used customised, sterilised cell culture
flasks with quartz windows in order to achieve this, and
showed that it is possible to follow the differentiation of these
cells by monitoring key biochemical changes that occur during
the process. The fact that the sterility of the culture was main-
tained in these experiments is significant, as the same cells
can be expanded and used in further experiments, saving time
and money over traditional characterisation techniques such
as flow cytometry and immunocytochemistry.75 While these
methods are not yet applicable to the clinic with a reduction
in differentiation seen in one study73 and long acquisition
times in the other,74 they further demonstrate the potential of
Raman spectroscopy in the identification and characterisation
of stem cell phenotype and, with further developments, may
be able to be translated into the clinic.
Pharmaceutical applications
Perhaps one of the most exciting potential applications of
Raman spectroscopy is in the study of pharmaceutical com-
pounds. In vitro studies of drug distribution and cellular
response can be monitored in real-time, potentially reducing
both the financial burden of the early stages of drug develop-
ment and the need for animal studies, especially in regards to
toxicity testing. Apoptosis, the cellular response to toxic
agents, can be detected by changes in the Raman spectra of
cells, and visualised by Raman mapping. This technique has
been used to show a build-up of lipids in the cytoplasm of eto-
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poside treated breast cancer cells,76 and the loss of cell volume
and cell shrinkage associated with docetaxel treatment in a
human adenocarcinoma cell line.77 If the drug of interest has
a peak in its Raman spectra that differs from or is outside the
range of the typical cellular components, then the drug itself
can be visualised intracellularly in a label-free manner. This
technique has been used to show the distribution of the anti-
cancer drug, paclitaxel, in a breast cancer cell line by measur-
ing the Raman peak at 1740 cm−1, representative of the CvO
bond vibration, to show the movement of the drug through the
cell membrane and into the cytoplasm.78
SERS is a particularly useful technique in this field, as
nanoparticles can be used not only to enhance the Raman
signal, but to aid cellular uptake of the drug of interest and
allow for targeted drug delivery. Gold-coated silver nano-
particles have been used to track the movement and cellular
metabolism of an anti-tumour drug, 6MP, in a human lung
adenocarcinoma cell line over a period of 24 hours,79
suggesting that SERS is an efficient method for studying drug
efficacy (demonstrated in Fig. 5). In addition, SERS nano-
particles can be designed not only to be conjugated to the
drug of interest, but also to have an outer layer that is pH sen-
sitive, allowing for pH-dependent drug release. This technique
has been used to deliver doxorubin to living cervical cancer
cells in vitro. The nanoparticles were conjugated with transfer-
rin, which is overexpressed in these cells, for specific targeting,
and SERS maps were constructed to show drug internalis-
ation.80 As most cancer cells exist within an acidic environ-
ment due to the nature of their metabolism,81 pH-sensitive
nanoparticles conjugated to toxic agents may represent a novel
way to develop new anti-cancer treatments.
Together, all of the above studies show the potential of
Raman microscopy in the development of pharmaceutical
compounds, not only for toxicity studies but to assess intra-
cellular distribution and the effect different drugs have on
different cell lines in addition to allowing for targeted delivery,
and suggest that Raman microscopy may be a feasible method
of predicting the in vivo response of a drug in vitro.
Diagnostics
Another major potential application of Raman spectroscopy is
in the diagnosis of disease. Many diseases originate from
underlying biochemical changes within cells, and as Raman
spectroscopy is able to detect these subtle changes, sometimes
with a high level of sensitivity, its potential in diagnostics
cannot be ignored. Raman spectroscopy could potentially be
used in the diagnosis of a number of different diseases from
atherosclerosis82,83 to osteoarthritis,84 but it is particularly
relevant in cancer research. As with fixed cells, Raman spec-
troscopy has been used to examine the differences between
normal and neoplastic living cells, mainly by their Raman
spectra,85,86 and SERS can be used to probe living cells for
specific markers. Many cancer cells express proteins that are
not usually found in normal cells of the same phenotype, and
detection of these proteins may aid in the diagnosis of
disease. The feasibility of SERS in this field has previously
been demonstrated in several studies. Both silver87 and gold88
nanoparticles conjugated to an antibody specific for HER2, a
receptor overexpressed on the surface of many breast cancer
cells, have been used in order to map these cells live (see
Fig. 6). There is the potential for this technique to be develo-
ped further and to be used in in vivo studies. Already, several
studies have been conducted on murine models, primarily col-
lecting Raman spectra rather than mapping individual cells
themselves,89,90 and there is the real possibility that these tech-
niques may be able to be developed further until they are clini-
Fig. 4 Fluorescent and Raman images demonstrating the differences between glial and neural stem cells. The Raman band at 788 cm−1 is associ-
ated with the nucleic acids of DNA and RNA, whilst the band at 813 cm−1 is associated with RNA only. High levels of RNA are observed in the cyto-
plasm neural stem cells, but RNA is absent in the cytoplasm of glial cells, demonstrating that Raman spectroscopy can be used to non-invasively
distinguish cell phenotype. Reproduced with permission from the American Chemical Society, Copyright 2012, ref. 72.
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cally relevant. The combination of Raman spectroscopy and
endoscopy has already been employed in the diagnosis of
oesophageal cancer with an accuracy of 96%,91 suggesting
that, with further development in order to distinguish between
healthy and cancerous tissue of other cells and tissues within
the body, Raman spectroscopy could become an important
clinical diagnostic tool in the future.
The use of SERS probes may also be particularly useful in
the detection of cancerous cells within solution, such as blood
or urine for non-invasive diagnosis of disease,92 with relevance
to leukaemia,93 and bladder cancer.94 The development of
optofluidic cell sorting systems has meant that single cells in
solution can be identified and sorted according to their
Raman spectra95 with a high specificity of 99% for the dis-
crimination of leukocytes, leukemic cells, and two different
breast cancer cell lines,96 giving further evidence towards the
use of Raman spectroscopy in this type of diagnosis.
Overall, these studies demonstrate the potential of Raman
spectroscopy in cancer diagnosis. Current diagnostic tech-
niques do not give accurate biochemical information about a
sample in the way that Raman spectroscopy is able to, and
often rely on examining visual differences that may be mis-
interpreted. There is therefore an interest in developing more
accurate techniques, and there is evidence that Raman spec-
troscopy may be a viable, label-free and non-invasive
alternative.
3D imaging
3D cell cultures are becoming an increasingly used and impor-
tant in vitro model in a number of different biological appli-
cations, from cellular differentiation to drug development, due
to their ability to more closely replicate the in vivo environment
than 2D models are currently able.97 While 2D cultures exist in
a single plane and can be captured by a single image, 3D cul-
tures are distributed over a number of planes in z-direction; as
such, analysis of 3D cultures has proved difficult as most tech-
niques currently in use were developed for 2D cultures. To
image 3D cultures, a number of images need to be acquired at
different focal positions (z-stack), and as confocal Raman spec-
troscopy is able to do this, it is an attractive option for the 3D
imaging of cell cultures.98 A good example of this approach is
demonstrated by Majzner et al. (Fig. 7) who successfully used
confocal Raman spectroscopy for the 3D mapping of individ-
ual endothelial cells in vitro and ex vivo within the vascular
wall.99
SERS nanotags have also been utilised to construct a 3D
image of Chinese Hamster Ovarian cells, demonstrating the
potential of SERS tags in detecting and mapping intracellular
structures.100 While in both of these studies, cells were fixed,
they show that Raman spectroscopy is a viable technique for
3D imaging in a non-disruptive manner that, if applied to live
cells, could lead to an increased understanding of cellular dys-
function in disease by detecting changes in the underlying
architecture. In the case of endothelial cells, it could lead to
the development of suitable models for vascular diseases, and
outlines the potential of 3D Raman mapping in diagnostics.
Fig. 5 Darkfield microscopy images (A), Raman maps (B) and Raman
spectra (C) to show the metabolism of 6MP in A549 cells over a period
of 24 hours. At 0 hour Raman intensity was mapped at 1286 cm−1 (peak
a) to show the distribution of 6MP. Subsequent maps use the Raman
intensity of 1330 cm−1 (peak b), representative of 6MPR, one of the
active anti-cancer agents formed from the breakdown of 6MP. 6MPR
began to form at 4 hours, and the concentration increased with increas-
ing time as the concentration of 6MP decreased. This demonstrates the
successful development of a label-free Raman based methodology to
monitor and visualise the metabolism of 6MP in living cells. Reproduced
with permission from the American Chemical Society, Copyright 2014,
ref. 79.
Fig. 6 SERS mapping images of a MCF7 cell expressing HER-2 using
hollow gold nanoparticles (a) and silver nanoparticles (b) specific for
HER-2 at 1620 cm−1, demonstrating the feasibility of using SERS probes
for cancer detection. Reproduced, with permission from Elsevier, Copy-
right 2009, ref. 87.
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SERS has been used for the 3D imaging of cellular pathways
within living cells. A gold nanoparticle was endocytosed by
macrophages and its movement tracked over time to show
interactions with intracellular structures associated with cellu-
lar transport e.g. microtubule-associated proteins dynein and
kinesin.101 The ability to track intracellular movement and
measure the interaction between nanoparticles and intracellu-
lar molecules in 3D is an exciting prospect in cell-based
studies, but particularly in drug development as it may allow
for the visualisation of drugs of interest in a 3D environment
close to in vivo conditions.
Conclusion
To summarise, Raman spectroscopy is a spectroscopic tech-
nique that detects molecular vibrations in order to characterise
the underlying chemical structure of a sample. It is particu-
larly relevant in biology as it allows for the non-invasive, label-
free observation and imaging of cells under normal physiologi-
cal conditions in a way that current imaging techniques
cannot. Raman imaging, especially live cell imaging, is a devel-
oping technique, and as we have demonstrated already shows
potential application in a number of different biomedical
fields. These include (but are not limited to): cell characteris-
ation and sorting; the development and testing of new
pharmaceutical compounds; the diagnosis and detection of
disease; and in 3D imaging. While there are still some limit-
ations of Raman spectroscopy, such as the time it takes to
acquire maps and a lack of robustness and consistency in the
way Raman maps are reported,34 there is hope that new devel-
opments and advancements can overcome this and lead to
Raman spectroscopy becoming a more accessible and widely-
used imaging technique in the future.
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